The latest at MBC Biolabs
The latest at MBC Biolabs
Celebrating “Small” Wins
Traditionally, most of the events we celebrate in life are the big milestones we accomplish – birthdays, graduation, retirement, the first round of investments. Often, we are too focused on the “goal” or the “outcome” that we forget about the small steppingstones along the way; the “small wins” in our day-to-day lives that drive the initiative to accomplish even bigger milestones.
Astellas Future Innovator Prize 2022
Apply until November 4, 2022, for Astellas Future Innovator Prize
Podcast: Building the Bay Area Life Sciences Startup Ecosystems
Lab to Startup Podcast with Regis Kelly and Doug Crawford
Siolta Therapeutics Announces First Newborn Dosed in Their Phase 2 ADORED Study
Siolta initiates dosing in newborn subjects in a groundbreaking trial of STMC-103H
Bristol Myers Squibb Golden Ticket 2022
Apply until August 22!
Eisai Golden Ticket 2022
Apply until August 22!
ONO Golden Ticket 2022 Winner
Weatherwax Biotechnologies is the winner!
Switch Bioworks Raises $4.3M to Feed a Growing World Sustainably
Next-generation biofertilizer startup sets out to tackle climate change with synthetic biology and microbes.
MBC BioLabs Announces New Partnership with Benchling
Benchling’s R&D Cloud makes it easier to capture and access the data you need, collaborate as a team, and accelerate decision making.
MBC BioLabs is Excited to Welcome Shimadzu as its Newest Partner
Shimadzu's Nexera Prep HPLC System is available at MBC BioLabs @ 930 Brittan.
AbbVie Golden Ticket Winners 2022
Qinotto and Think Bioscience are the winners of the AbbVie 2022 Golden Ticket Competition.
ONO Golden Ticket 2022
Apply until May 6!
Dorian Therapeutics
The Discovery to Youthfulness and Regeneration
AbbVie Golden Ticket 2022
Apply until February 18
Dren Bio Announces Research Collaboration and License Agreement with Pfizer
Dren Bio received $25 million upfront payment as part of overall deal for selected oncology targets that includes over $1 billion in potential cash payments plus potential future product-based sales royalties
AbbVie Golden Ticket Winners 2021
Regel Therapeutics and Weatherwax Bio are the winners of the "AbbVie 2021 Golden Ticket Competition".
Astellas Future Innovator Prize Winners 2021
Vcreate and Weatherwax Biotechnologies win a year of access to life-science incubator in San Francisco, CA and to Astellas expertise to further their research.
Eisai Innovation, Inc. Golden Ticket 2021 Winner
Deciduous Therapeutics was selected as the winner of the 2021 Eisai Golden Ticket Competition
Eisai and MBC BioLabs Announce Winner of Golden Ticket Competition
Eisai and MBC BioLabs Announce Winner of Golden Ticket Competition to Support Biotech Start-ups Accelerate Early Drug Discovery
Astellas Future Innovator Prize 2021
Astellas and MBC BioLabs announce their third collaboration on the "Future Innovator Prize" formerly known as Astellas Golden Ticket.
Eisai Innovation, Inc. Golden Ticket 2021
Eisai Innovation and MBC BioLabs Announce 2021 Eisai Golden Ticket Competition to Accele [...]
MBC BioLabs welcomes Eisai Innovation, Inc. as our newest partner
MBC BioLabs is thrilled to announce our latest partner is Eisai Innovation, Inc. (EII), an affiliate of Eisai Co., Ltd. the fully integrated pharmaceutical company based in Tokyo, Japan.
Bristol Myers Squibb Golden Ticket 2021
Apply now for one year free bench space!
Revel Pharmaceuticals revels in new Agilent program
Revel has tapped the Agilent Instrument Subscriptions Program to gain access to a mass spectrometer, critical in the startup’s work to combat the damages of aging.